Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium chloride 0.9% neb liq 2.5ml unit dose ampoules
1202020L0AACCCC
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 32,813 |
|
Sodium chloride 3% nebuliser liquid
1202020L0AABZBZ
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 18 |
|
Sodium chloride 3% nebuliser liquid 10ml unit dose vials
1202020L0AACACA
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 10 |
|
Sodium chloride 7% nebuliser liquid
1202020L0AABQBQ
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 8 |
|
Sodium chloride 7% nebuliser liquid 5ml bottles
1202020L0AACDCD
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 8 |
|
Sodium chloride 7% nebuliser liquid 5ml ampoules
1202020L0AABNBN
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 3 |
|
Sodium chloride 0.9% nebuliser liquid 20ml unit dose vials
1202020L0AABEBE
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 2 |
|
Sodium chloride 3% nebuliser liquid 20ml unit dose vials
1202020L0AACBCB
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.